What is Intelligent Retinal Imaging Systems?
Intelligent Retinal Imaging Systems (IRIS) provides IRIS, a camera-agnostic, cloud-based retinal screening software designed to empower healthcare providers. This solution integrates seamlessly into existing clinical workflows, enabling efficient retinal screenings for conditions like diabetic retinopathy. IRIS targets hospitals, health systems, and health plans, aiming to bridge care gaps and reduce healthcare costs by making quality retinal examinations more accessible and preventing avoidable blindness.
How much funding has Intelligent Retinal Imaging Systems raised?
Intelligent Retinal Imaging Systems has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$733K
Debt (2020): $350K with participation from PPP
Debt (2021): $733K led by PPP
What's next for Intelligent Retinal Imaging Systems?
The recent major strategic investment signifies a critical growth phase for Intelligent Retinal Imaging Systems. This capital infusion is expected to fuel further development of their IRIS platform, expand market reach into new healthcare systems, and potentially enhance integration capabilities with diverse EMR/EHR systems. The company is poised to solidify its position as a leader in preventative eye care technology, addressing a significant public health challenge.
See full Intelligent Retinal Imaging Systems company page
